 | • レポートコード：MRC2-11QY05032 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はウイルス不活化のグローバル市場について調査・分析したレポートです。種類別（キットおよび試薬、サービス、ウイルス不活化システムおよび付属品）市場規模、用途別（血液および血液製剤、細胞および遺伝子治療製品、幹細胞製品、組織および組織製品、ワクチンおよび治療薬）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ウイルス不活化の競争状況、市場シェア ・世界のウイルス不活化市場：種類別市場規模 2015年-2020年（キットおよび試薬、サービス、ウイルス不活化システムおよび付属品） ・世界のウイルス不活化市場：種類別市場規模予測 2021年-2026年（キットおよび試薬、サービス、ウイルス不活化システムおよび付属品） ・世界のウイルス不活化市場：用途別市場規模 2015年-2020年（血液および血液製剤、細胞および遺伝子治療製品、幹細胞製品、組織および組織製品、ワクチンおよび治療薬） ・世界のウイルス不活化市場：用途別市場規模予測 2021年-2026年（血液および血液製剤、細胞および遺伝子治療製品、幹細胞製品、組織および組織製品、ワクチンおよび治療薬） ・北米のウイルス不活化市場分析：米国、カナダ ・ヨーロッパのウイルス不活化市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのウイルス不活化市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のウイルス不活化市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのウイルス不活化市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Danaher、Merck、Parker Hannifin、Sartorius、SGS、Charles River Laboratories International、Clean Cells、Rad Source Technologies、Texcell、Viral Inactivated Plasma Systems、Wuxi Pharmatech (Cayman) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Market Analysis and Insights: Global Viral Inactivation Market
The global Viral Inactivation market size is projected to reach US$ 393.2 million by 2026, from US$ 365.6 million in 2020, at a CAGR of 7.0%% during 2021-2026.
Global Viral Inactivation Scope and Market Size
Viral Inactivation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Inactivation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Market segment by Type, the product can be split into
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Market segment by Application, split into
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Inactivation Revenue
1.4 Market by Type
1.4.1 Global Viral Inactivation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kits and Reagents
1.4.3 Services
1.4.4 Viral Inactivation Systems and Accessories
1.5 Market by Application
1.5.1 Global Viral Inactivation Market Share by Application: 2020 VS 2026
1.5.2 Blood and Blood Products
1.5.3 Cellular and Gene Therapy Products
1.5.4 Stem Cell Products
1.5.5 Tissue and Tissue Products
1.5.6 Vaccines and Therapeutics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Viral Inactivation Market Perspective (2015-2026)
2.2 Global Viral Inactivation Growth Trends by Regions
2.2.1 Viral Inactivation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Viral Inactivation Historic Market Share by Regions (2015-2020)
2.2.3 Viral Inactivation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Viral Inactivation Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Inactivation Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Viral Inactivation Players by Market Size
3.1.1 Global Top Viral Inactivation Players by Revenue (2015-2020)
3.1.2 Global Viral Inactivation Revenue Market Share by Players (2015-2020)
3.1.3 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Inactivation Market Concentration Ratio
3.2.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2019
3.3 Viral Inactivation Key Players Head office and Area Served
3.4 Key Players Viral Inactivation Product Solution and Service
3.5 Date of Enter into Viral Inactivation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Viral Inactivation Historic Market Size by Type (2015-2020)
4.2 Global Viral Inactivation Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Viral Inactivation Market Size by Application (2015-2020)
5.2 Global Viral Inactivation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Viral Inactivation Market Size (2015-2020)
6.2 Viral Inactivation Key Players in North America (2019-2020)
6.3 North America Viral Inactivation Market Size by Type (2015-2020)
6.4 North America Viral Inactivation Market Size by Application (2015-2020)
7 Europe
7.1 Europe Viral Inactivation Market Size (2015-2020)
7.2 Viral Inactivation Key Players in Europe (2019-2020)
7.3 Europe Viral Inactivation Market Size by Type (2015-2020)
7.4 Europe Viral Inactivation Market Size by Application (2015-2020)
8 China
8.1 China Viral Inactivation Market Size (2015-2020)
8.2 Viral Inactivation Key Players in China (2019-2020)
8.3 China Viral Inactivation Market Size by Type (2015-2020)
8.4 China Viral Inactivation Market Size by Application (2015-2020)
9 Japan
9.1 Japan Viral Inactivation Market Size (2015-2020)
9.2 Viral Inactivation Key Players in Japan (2019-2020)
9.3 Japan Viral Inactivation Market Size by Type (2015-2020)
9.4 Japan Viral Inactivation Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Viral Inactivation Market Size (2015-2020)
10.2 Viral Inactivation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Inactivation Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Inactivation Market Size by Application (2015-2020)
11 India
11.1 India Viral Inactivation Market Size (2015-2020)
11.2 Viral Inactivation Key Players in India (2019-2020)
11.3 India Viral Inactivation Market Size by Type (2015-2020)
11.4 India Viral Inactivation Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Viral Inactivation Market Size (2015-2020)
12.2 Viral Inactivation Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Inactivation Market Size by Type (2015-2020)
12.4 Central & South America Viral Inactivation Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Danaher
13.1.1 Danaher Company Details
13.1.2 Danaher Business Overview
13.1.3 Danaher Viral Inactivation Introduction
13.1.4 Danaher Revenue in Viral Inactivation Business (2015-2020))
13.1.5 Danaher Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Viral Inactivation Introduction
13.2.4 Merck Revenue in Viral Inactivation Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Parker Hannifin
13.3.1 Parker Hannifin Company Details
13.3.2 Parker Hannifin Business Overview
13.3.3 Parker Hannifin Viral Inactivation Introduction
13.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2015-2020)
13.3.5 Parker Hannifin Recent Development
13.4 Sartorius
13.4.1 Sartorius Company Details
13.4.2 Sartorius Business Overview
13.4.3 Sartorius Viral Inactivation Introduction
13.4.4 Sartorius Revenue in Viral Inactivation Business (2015-2020)
13.4.5 Sartorius Recent Development
13.5 SGS
13.5.1 SGS Company Details
13.5.2 SGS Business Overview
13.5.3 SGS Viral Inactivation Introduction
13.5.4 SGS Revenue in Viral Inactivation Business (2015-2020)
13.5.5 SGS Recent Development
13.6 Charles River Laboratories International
13.6.1 Charles River Laboratories International Company Details
13.6.2 Charles River Laboratories International Business Overview
13.6.3 Charles River Laboratories International Viral Inactivation Introduction
13.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2015-2020)
13.6.5 Charles River Laboratories International Recent Development
13.7 Clean Cells
13.7.1 Clean Cells Company Details
13.7.2 Clean Cells Business Overview
13.7.3 Clean Cells Viral Inactivation Introduction
13.7.4 Clean Cells Revenue in Viral Inactivation Business (2015-2020)
13.7.5 Clean Cells Recent Development
13.8 Rad Source Technologies
13.8.1 Rad Source Technologies Company Details
13.8.2 Rad Source Technologies Business Overview
13.8.3 Rad Source Technologies Viral Inactivation Introduction
13.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2015-2020)
13.8.5 Rad Source Technologies Recent Development
13.9 Texcell
13.9.1 Texcell Company Details
13.9.2 Texcell Business Overview
13.9.3 Texcell Viral Inactivation Introduction
13.9.4 Texcell Revenue in Viral Inactivation Business (2015-2020)
13.9.5 Texcell Recent Development
13.10 Viral Inactivated Plasma Systems
13.10.1 Viral Inactivated Plasma Systems Company Details
13.10.2 Viral Inactivated Plasma Systems Business Overview
13.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
13.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2015-2020)
13.10.5 Viral Inactivated Plasma Systems Recent Development
13.11 Wuxi Pharmatech (Cayman)
10.11.1 Wuxi Pharmatech (Cayman) Company Details
10.11.2 Wuxi Pharmatech (Cayman) Business Overview
10.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
10.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2015-2020)
10.11.5 Wuxi Pharmatech (Cayman) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Viral Inactivation Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Inactivation Revenue
Table 3. Ranking of Global Top Viral Inactivation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Inactivation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Kits and Reagents
Table 6. Key Players of Services
Table 7. Key Players of Viral Inactivation Systems and Accessories
Table 8. Global Viral Inactivation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Viral Inactivation Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Viral Inactivation Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Viral Inactivation Market Share by Regions (2015-2020)
Table 12. Global Viral Inactivation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Viral Inactivation Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Viral Inactivation Market Growth Strategy
Table 18. Main Points Interviewed from Key Viral Inactivation Players
Table 19. Global Viral Inactivation Revenue by Players (2015-2020) (Million US$)
Table 20. Global Viral Inactivation Market Share by Players (2015-2020)
Table 21. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Inactivation as of 2019)
Table 22. Global Viral Inactivation by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Viral Inactivation Product Solution and Service
Table 25. Date of Enter into Viral Inactivation Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Inactivation Market Size by Type (2015-2020) (Million US$)
Table 28. Global Viral Inactivation Market Size Share by Type (2015-2020)
Table 29. Global Viral Inactivation Revenue Market Share by Type (2021-2026)
Table 30. Global Viral Inactivation Market Size Share by Application (2015-2020)
Table 31. Global Viral Inactivation Market Size by Application (2015-2020) (Million US$)
Table 32. Global Viral Inactivation Market Size Share by Application (2021-2026)
Table 33. North America Key Players Viral Inactivation Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Viral Inactivation Market Share (2019-2020)
Table 35. North America Viral Inactivation Market Size by Type (2015-2020) (Million US$)
Table 36. North America Viral Inactivation Market Share by Type (2015-2020)
Table 37. North America Viral Inactivation Market Size by Application (2015-2020) (Million US$)
Table 38. North America Viral Inactivation Market Share by Application (2015-2020)
Table 39. Europe Key Players Viral Inactivation Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Viral Inactivation Market Share (2019-2020)
Table 41. Europe Viral Inactivation Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Viral Inactivation Market Share by Type (2015-2020)
Table 43. Europe Viral Inactivation Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Viral Inactivation Market Share by Application (2015-2020)
Table 45. China Key Players Viral Inactivation Revenue (2019-2020) (Million US$)
Table 46. China Key Players Viral Inactivation Market Share (2019-2020)
Table 47. China Viral Inactivation Market Size by Type (2015-2020) (Million US$)
Table 48. China Viral Inactivation Market Share by Type (2015-2020)
Table 49. China Viral Inactivation Market Size by Application (2015-2020) (Million US$)
Table 50. China Viral Inactivation Market Share by Application (2015-2020)
Table 51. Japan Key Players Viral Inactivation Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Viral Inactivation Market Share (2019-2020)
Table 53. Japan Viral Inactivation Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Viral Inactivation Market Share by Type (2015-2020)
Table 55. Japan Viral Inactivation Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Viral Inactivation Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Viral Inactivation Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Viral Inactivation Market Share (2019-2020)
Table 59. Southeast Asia Viral Inactivation Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Viral Inactivation Market Share by Type (2015-2020)
Table 61. Southeast Asia Viral Inactivation Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Viral Inactivation Market Share by Application (2015-2020)
Table 63. India Key Players Viral Inactivation Revenue (2019-2020) (Million US$)
Table 64. India Key Players Viral Inactivation Market Share (2019-2020)
Table 65. India Viral Inactivation Market Size by Type (2015-2020) (Million US$)
Table 66. India Viral Inactivation Market Share by Type (2015-2020)
Table 67. India Viral Inactivation Market Size by Application (2015-2020) (Million US$)
Table 68. India Viral Inactivation Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Viral Inactivation Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Viral Inactivation Market Share (2019-2020)
Table 71. Central & South America Viral Inactivation Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Viral Inactivation Market Share by Type (2015-2020)
Table 73. Central & South America Viral Inactivation Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Viral Inactivation Market Share by Application (2015-2020)
Table 75. Danaher Company Details
Table 76. Danaher Business Overview
Table 77. Danaher Product
Table 78. Danaher Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 79. Danaher Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Product
Table 83. Merck Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 84. Merck Recent Development
Table 85. Parker Hannifin Company Details
Table 86. Parker Hannifin Business Overview
Table 87. Parker Hannifin Product
Table 88. Parker Hannifin Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 89. Parker Hannifin Recent Development
Table 90. Sartorius Company Details
Table 91. Sartorius Business Overview
Table 92. Sartorius Product
Table 93. Sartorius Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 94. Sartorius Recent Development
Table 95. SGS Company Details
Table 96. SGS Business Overview
Table 97. SGS Product
Table 98. SGS Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 99. SGS Recent Development
Table 100. Charles River Laboratories International Company Details
Table 101. Charles River Laboratories International Business Overview
Table 102. Charles River Laboratories International Product
Table 103. Charles River Laboratories International Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 104. Charles River Laboratories International Recent Development
Table 105. Clean Cells Company Details
Table 106. Clean Cells Business Overview
Table 107. Clean Cells Product
Table 108. Clean Cells Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 109. Clean Cells Recent Development
Table 110. Rad Source Technologies Business Overview
Table 111. Rad Source Technologies Product
Table 112. Rad Source Technologies Company Details
Table 113. Rad Source Technologies Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 114. Rad Source Technologies Recent Development
Table 115. Texcell Company Details
Table 116. Texcell Business Overview
Table 117. Texcell Product
Table 118. Texcell Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 119. Texcell Recent Development
Table 120. Viral Inactivated Plasma Systems Company Details
Table 121. Viral Inactivated Plasma Systems Business Overview
Table 122. Viral Inactivated Plasma Systems Product
Table 123. Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 124. Viral Inactivated Plasma Systems Recent Development
Table 125. Wuxi Pharmatech (Cayman) Company Details
Table 126. Wuxi Pharmatech (Cayman) Business Overview
Table 127. Wuxi Pharmatech (Cayman) Product
Table 128. Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2015-2020) (Million US$)
Table 129. Wuxi Pharmatech (Cayman) Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Inactivation Market Share by Type: 2020 VS 2026
Figure 2. Kits and Reagents Features
Figure 3. Services Features
Figure 4. Viral Inactivation Systems and Accessories Features
Figure 5. Global Viral Inactivation Market Share by Application: 2020 VS 2026
Figure 6. Blood and Blood Products Case Studies
Figure 7. Cellular and Gene Therapy Products Case Studies
Figure 8. Stem Cell Products Case Studies
Figure 9. Tissue and Tissue Products Case Studies
Figure 10. Vaccines and Therapeutics Case Studies
Figure 11. Viral Inactivation Report Years Considered
Figure 12. Global Viral Inactivation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Viral Inactivation Market Share by Regions: 2020 VS 2026
Figure 14. Global Viral Inactivation Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Viral Inactivation Market Share by Players in 2019
Figure 17. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Inactivation as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Viral Inactivation Revenue in 2019
Figure 19. North America Viral Inactivation Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Viral Inactivation Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Viral Inactivation Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Viral Inactivation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Viral Inactivation Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Viral Inactivation Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Viral Inactivation Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
ウイルスクリアランスの世界市場（～2026年） The viral clearance market in the region is driven by the presence of national institutes supporting biotechnology and life science research, growth in the pharmaceuticals industry, and the increasing number of drug approvals. While this is a high-growth market, the high time and cost requirements f…- ウイルスベクター製造の世界市場（～2026年） Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells. Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors bas…
- ウイルス性結膜炎治療薬の世界市場（～2026年） Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely t…
- ウイルス分子診断の世界市場（～2026年） Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastru…
- ウイルス性結膜炎パイプライン薬剤の世界市場（～2026年） Market Analysis and Insights: Global Viral Conjunctivitis Pipeline Drugs Market The global Viral Conjunctivitis Pipeline Drugs market size is projected to reach US$ 51 million by 2026, from US$ 36 million in 2020, at a CAGR of 39.5%% during 2021-2026. Global Viral Conjunctivitis Pipeline Drugs Scope…